Where does NantBio, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NantBio, Inc. ranks #6,569 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NantBio, Inc. hold?

NantBio, Inc. holds 51 US utility patents granted between 2018 and 2025, spanning 19 technology areas.

What is NantBio, Inc.'s Innovation Score?

NantBio, Inc. has an Innovation Score of 44.4 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NantBio, Inc. focus on?

NantBio, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 33 patents, ranking #676 of 7,163 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

Is NantBio, Inc.'s patent grant rate increasing or decreasing?

NantBio, Inc.'s recent grant velocity is +433% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for NantBio, Inc.'s patents?

NantBio, Inc.'s patents average 12.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NantBio, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NantBio, Inc.

USPTO PatentsView assignee record - 51 granted patents across 19 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nantbio ranks #6,569 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 19 technology areas.

#6,569
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.4/100): 12.6
avg claims per patent: +433%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6569 · US Corporation #6,569 · 51 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 51 grants
UPPER-Q #6,569/49,997
PHOTO-FINISH Microsemi
CPC-FOCUS A61K · 19 areas
INNOV-PAR 44.4/100
CLAIMS-RICH 12.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +433% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Microsemi Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nantbio’s 44.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (31%) Velocity 7.8 pts (18%) Breadth 15.4 pts (35%) Claim depth 7.5 pts (17%)

Qualcomm Incorporated · highest

85
Crispr Therapeutics · near

44
Elenion · near

44
NantBio · this assignee

44
National Chain · near

44
Sunnybrook Health… · near

44
3D Lighting… · lowest

7

What this shows Nantbio's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nantbio?

Each dot is one of Nantbio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nantbio’s own 12.6 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Nantbio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nantbio's grants concentrate

NantBio, Inc. is a focused PatentsView assignee: 19 CPC subclasses with 64.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (10 grants) versus a trough of 1 in 2018. By volume, Nantbio sits between Microsemi Corporation and Optical Logic Inc..

Nantbio's three-year grant acceleration

NantBio, Inc. shows 20 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Microsemi

51
Mississippi State…

51
Neopost

51
Nissin Foods Hold…

51
National Oilwell…

51
Nokia Solutions a…

51
Nokomis

51
Optical Logic

51
Nantbio ◀

51

What this shows NantBio holds 51 patents at rank #6,571, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NantBio

By rank, the assignees closest to #6,571 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in NantBio's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for NantBio, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), NantBio ranks #676 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

National Chain Company 44 Crispr Therapeutics AG 44 Sunnybrook Health Sciences Centre 44 Elenion Technologies, LLC 44

Similar claim depth

Nearest assignees by average claims per patent (12.6 here).

INDUSTRY—UNIVERSITY Cooperation Foundation Korea Aerospace University 12.6 avg Terumo BCT, Inc. 12.6 avg Husqvarna AB 12.6 avg Harman International Industries, Incorporated 12.6 avg

Nantbio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

NantBio, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	2.0%
2019	5	9.8%
2020	10	19.6%
2021	2	3.9%
2022	4	7.8%
2023	7	13.7%
2024	9	17.6%
2025partial year	13	25.5%

Which technologies does NantBio, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 33

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 25

C07K - Peptides 21

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 19

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C07D - Heterocyclic Compounds 7

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C12Y - Enzymes 1

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NantBio, Inc.'s patent record in context - here's where to go next.

NantBio, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 64.7% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #6,569 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NantBio, Inc. against Microsemi Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.